Phase II trials in heart failure: the role of cardiovascular imaging.


The development of new therapies for heart failure (HF), especially acute HF, has proven to be quite challenging; and therapies evaluated in HF have greatly outnumbered treatments that are eventually successful in obtaining regulatory approval. Thus, the development of therapies for HF remains a vexing problem for pharmaceutical and device companies… (More)
DOI: 10.1016/j.ahj.2011.03.031


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics